 Matthew Zipse
Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Catheter Ablation | 20 | 2023 | 288 | 4.050 |
Why?
| | Cardiomyopathies | 14 | 2023 | 298 | 3.730 |
Why?
| | Sarcoidosis | 12 | 2023 | 135 | 3.510 |
Why?
| | Atrial Fibrillation | 7 | 2023 | 322 | 1.990 |
Why?
| | Defibrillators, Implantable | 10 | 2023 | 286 | 1.470 |
Why?
| | Tachycardia, Ventricular | 9 | 2022 | 152 | 1.430 |
Why?
| | Pacemaker, Artificial | 4 | 2023 | 106 | 1.360 |
Why?
| | Heart Ventricles | 6 | 2020 | 712 | 1.360 |
Why?
| | Arrhythmias, Cardiac | 5 | 2022 | 279 | 1.150 |
Why?
| | Myocarditis | 3 | 2023 | 93 | 1.140 |
Why?
| | Electrophysiologic Techniques, Cardiac | 4 | 2019 | 70 | 1.010 |
Why?
| | Death, Sudden, Cardiac | 5 | 2022 | 160 | 1.010 |
Why?
| | Therapeutic Irrigation | 3 | 2020 | 67 | 0.980 |
Why?
| | Heart Valve Prosthesis | 2 | 2016 | 121 | 0.920 |
Why?
| | Atrial Appendage | 1 | 2023 | 10 | 0.880 |
Why?
| | Myocardium | 6 | 2022 | 913 | 0.870 |
Why?
| | Electric Countershock | 5 | 2023 | 104 | 0.860 |
Why?
| | Electrocardiography | 7 | 2023 | 560 | 0.850 |
Why?
| | Cardiac Pacing, Artificial | 4 | 2023 | 77 | 0.810 |
Why?
| | Ventricular Function, Right | 3 | 2020 | 250 | 0.760 |
Why?
| | Cardiac Resynchronization Therapy | 2 | 2021 | 42 | 0.700 |
Why?
| | Pericardium | 1 | 2020 | 50 | 0.670 |
Why?
| | Cardiac Catheters | 4 | 2020 | 15 | 0.630 |
Why?
| | Ventricular Function, Left | 2 | 2019 | 467 | 0.610 |
Why?
| | Prosthesis Failure | 2 | 2020 | 115 | 0.600 |
Why?
| | Septal Occluder Device | 1 | 2018 | 46 | 0.570 |
Why?
| | Action Potentials | 2 | 2019 | 406 | 0.560 |
Why?
| | Tricuspid Valve | 2 | 2019 | 25 | 0.560 |
Why?
| | Heart Rate | 2 | 2019 | 709 | 0.540 |
Why?
| | Heart Atria | 4 | 2023 | 107 | 0.530 |
Why?
| | Mitral Valve | 2 | 2019 | 86 | 0.530 |
Why?
| | Adipose Tissue | 1 | 2020 | 545 | 0.530 |
Why?
| | Ebstein Anomaly | 1 | 2016 | 6 | 0.520 |
Why?
| | Adiposity | 1 | 2020 | 458 | 0.490 |
Why?
| | Cardiac Catheterization | 2 | 2020 | 534 | 0.490 |
Why?
| | Pulmonary Veins | 1 | 2016 | 81 | 0.480 |
Why?
| | Friedreich Ataxia | 1 | 2016 | 64 | 0.480 |
Why?
| | Electroshock | 1 | 2014 | 134 | 0.460 |
Why?
| | Electrophysiological Phenomena | 1 | 2013 | 48 | 0.430 |
Why?
| | Endovascular Procedures | 1 | 2016 | 269 | 0.390 |
Why?
| | Heart Failure | 5 | 2021 | 1945 | 0.390 |
Why?
| | Heart Septum | 3 | 2016 | 26 | 0.370 |
Why?
| | Tachycardia, Atrioventricular Nodal Reentry | 2 | 2021 | 28 | 0.360 |
Why?
| | Heart Conduction System | 3 | 2023 | 80 | 0.360 |
Why?
| | Ventricular Premature Complexes | 2 | 2022 | 25 | 0.360 |
Why?
| | Cattle | 8 | 2020 | 920 | 0.350 |
Why?
| | Humans | 41 | 2023 | 114699 | 0.340 |
Why?
| | Cardiomyopathy, Hypertrophic | 3 | 2016 | 121 | 0.330 |
Why?
| | Transcatheter Aortic Valve Replacement | 2 | 2023 | 152 | 0.320 |
Why?
| | Aortic Valve Stenosis | 2 | 2023 | 272 | 0.290 |
Why?
| | Electrodes | 2 | 2018 | 100 | 0.290 |
Why?
| | Anti-Arrhythmia Agents | 3 | 2023 | 106 | 0.280 |
Why?
| | Aged | 15 | 2021 | 19074 | 0.270 |
Why?
| | Ethanol | 3 | 2016 | 538 | 0.270 |
Why?
| | Time Factors | 7 | 2020 | 6116 | 0.260 |
Why?
| | Risk Assessment | 5 | 2020 | 2968 | 0.260 |
Why?
| | Postoperative Complications | 4 | 2020 | 2128 | 0.250 |
Why?
| | Male | 24 | 2022 | 55606 | 0.250 |
Why?
| | Ablation Techniques | 2 | 2016 | 29 | 0.250 |
Why?
| | Stroke Volume | 4 | 2022 | 504 | 0.250 |
Why?
| | Equipment Design | 4 | 2020 | 508 | 0.240 |
Why?
| | In Vitro Techniques | 3 | 2020 | 1016 | 0.220 |
Why?
| | Heart | 4 | 2022 | 612 | 0.210 |
Why?
| | Aortic Valve | 3 | 2023 | 398 | 0.200 |
Why?
| | Middle Aged | 16 | 2022 | 26738 | 0.190 |
Why?
| | Atrial Flutter | 1 | 2021 | 25 | 0.190 |
Why?
| | Tachycardia, Supraventricular | 1 | 2021 | 42 | 0.190 |
Why?
| | Esophagus | 2 | 2023 | 225 | 0.180 |
Why?
| | Coronary Sinus | 1 | 2020 | 7 | 0.180 |
Why?
| | Echocardiography | 3 | 2019 | 553 | 0.180 |
Why?
| | Bradycardia | 1 | 2021 | 48 | 0.180 |
Why?
| | Cardiac Output | 1 | 2020 | 143 | 0.180 |
Why?
| | Accessory Atrioventricular Bundle | 2 | 2020 | 11 | 0.180 |
Why?
| | Heart Transplantation | 2 | 2023 | 665 | 0.170 |
Why?
| | Retrospective Studies | 9 | 2023 | 12555 | 0.170 |
Why?
| | Operative Time | 1 | 2020 | 106 | 0.170 |
Why?
| | Papillary Muscles | 1 | 2019 | 14 | 0.170 |
Why?
| | Tricuspid Valve Insufficiency | 1 | 2019 | 19 | 0.170 |
Why?
| | Treatment Outcome | 8 | 2023 | 9088 | 0.160 |
Why?
| | Prosthesis-Related Infections | 1 | 2020 | 70 | 0.160 |
Why?
| | Aortic Valve Insufficiency | 1 | 2019 | 45 | 0.160 |
Why?
| | Myocardial Contraction | 1 | 2020 | 313 | 0.160 |
Why?
| | Esophageal Fistula | 1 | 2019 | 17 | 0.160 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2019 | 54 | 0.160 |
Why?
| | Mitral Valve Insufficiency | 1 | 2019 | 63 | 0.160 |
Why?
| | Systole | 1 | 2019 | 171 | 0.160 |
Why?
| | Device Removal | 1 | 2020 | 126 | 0.160 |
Why?
| | Atrioventricular Block | 1 | 2019 | 37 | 0.160 |
Why?
| | Prosthesis Implantation | 1 | 2019 | 138 | 0.150 |
Why?
| | Heart Diseases | 2 | 2012 | 331 | 0.150 |
Why?
| | Bundle-Branch Block | 2 | 2023 | 28 | 0.150 |
Why?
| | Risk Factors | 6 | 2023 | 8632 | 0.150 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2020 | 217 | 0.140 |
Why?
| | Endocardium | 1 | 2017 | 30 | 0.140 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2021 | 358 | 0.140 |
Why?
| | Intraoperative Complications | 1 | 2018 | 122 | 0.140 |
Why?
| | Environment | 1 | 2018 | 332 | 0.140 |
Why?
| | Swine | 4 | 2023 | 700 | 0.130 |
Why?
| | Predictive Value of Tests | 2 | 2019 | 1796 | 0.130 |
Why?
| | Tachycardia, Reciprocating | 1 | 2016 | 6 | 0.130 |
Why?
| | Catheters | 1 | 2016 | 63 | 0.130 |
Why?
| | Wolff-Parkinson-White Syndrome | 1 | 2016 | 16 | 0.130 |
Why?
| | Heart Injuries | 1 | 2016 | 37 | 0.130 |
Why?
| | Female | 17 | 2022 | 59520 | 0.120 |
Why?
| | Hospitals | 1 | 2019 | 581 | 0.120 |
Why?
| | Heart Block | 1 | 2015 | 38 | 0.120 |
Why?
| | Heart-Assist Devices | 1 | 2020 | 485 | 0.120 |
Why?
| | Diagnostic Techniques, Cardiovascular | 1 | 2014 | 11 | 0.120 |
Why?
| | Incidence | 5 | 2021 | 2313 | 0.120 |
Why?
| | Ultrasonography | 1 | 2017 | 634 | 0.120 |
Why?
| | Medical Records | 1 | 2015 | 153 | 0.110 |
Why?
| | Artifacts | 1 | 2014 | 114 | 0.110 |
Why?
| | Sarcoidosis, Pulmonary | 2 | 2011 | 58 | 0.110 |
Why?
| | Animals | 9 | 2023 | 31708 | 0.110 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2014 | 133 | 0.110 |
Why?
| | Prosthesis Design | 1 | 2014 | 285 | 0.100 |
Why?
| | Disease Progression | 1 | 2019 | 2380 | 0.100 |
Why?
| | Adult | 10 | 2022 | 30553 | 0.100 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2017 | 1214 | 0.100 |
Why?
| | Cardiac Surgical Procedures | 1 | 2016 | 414 | 0.100 |
Why?
| | Prognosis | 1 | 2019 | 3329 | 0.100 |
Why?
| | Exercise | 1 | 2020 | 1644 | 0.090 |
Why?
| | Tomography, X-Ray Computed | 1 | 2019 | 2286 | 0.080 |
Why?
| | Disease Management | 1 | 2013 | 560 | 0.080 |
Why?
| | Patient Discharge | 1 | 2015 | 773 | 0.080 |
Why?
| | Temperature | 2 | 2023 | 565 | 0.080 |
Why?
| | Follow-Up Studies | 4 | 2019 | 4411 | 0.080 |
Why?
| | Bundle of His | 1 | 2023 | 14 | 0.060 |
Why?
| | Databases, Factual | 2 | 2020 | 1125 | 0.050 |
Why?
| | Registries | 2 | 2021 | 1768 | 0.050 |
Why?
| | Atrioventricular Node | 1 | 2021 | 14 | 0.050 |
Why?
| | Artificial Intelligence | 1 | 2023 | 144 | 0.050 |
Why?
| | Tachycardia | 1 | 2021 | 50 | 0.050 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2022 | 113 | 0.050 |
Why?
| | Radiopharmaceuticals | 1 | 2022 | 157 | 0.050 |
Why?
| | Positron-Emission Tomography | 1 | 2022 | 259 | 0.040 |
Why?
| | Mortality | 1 | 2022 | 287 | 0.040 |
Why?
| | Recurrence | 1 | 2022 | 935 | 0.040 |
Why?
| | Necrosis | 1 | 2019 | 211 | 0.040 |
Why?
| | Sus scrofa | 1 | 2018 | 45 | 0.040 |
Why?
| | United States | 3 | 2021 | 12186 | 0.040 |
Why?
| | Electric Impedance | 1 | 2018 | 100 | 0.040 |
Why?
| | Multivariate Analysis | 1 | 2022 | 1430 | 0.040 |
Why?
| | Exercise Test | 1 | 2020 | 544 | 0.040 |
Why?
| | Myocardial Ischemia | 1 | 2019 | 235 | 0.040 |
Why?
| | Activities of Daily Living | 1 | 2020 | 349 | 0.040 |
Why?
| | Hot Temperature | 1 | 2019 | 302 | 0.040 |
Why?
| | Biophysical Phenomena | 1 | 2017 | 63 | 0.040 |
Why?
| | Prosthesis Fitting | 1 | 2016 | 13 | 0.030 |
Why?
| | Thermal Conductivity | 1 | 2016 | 5 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2020 | 1342 | 0.030 |
Why?
| | Colorado | 2 | 2019 | 4100 | 0.030 |
Why?
| | Reoperation | 1 | 2018 | 514 | 0.030 |
Why?
| | Hospital Mortality | 1 | 2020 | 776 | 0.030 |
Why?
| | Medicare | 1 | 2021 | 665 | 0.030 |
Why?
| | Prospective Studies | 2 | 2019 | 6220 | 0.030 |
Why?
| | Models, Animal | 1 | 2017 | 344 | 0.030 |
Why?
| | Models, Cardiovascular | 1 | 2016 | 178 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 1644 | 0.030 |
Why?
| | Hospitals, Low-Volume | 1 | 2015 | 22 | 0.030 |
Why?
| | Retreatment | 1 | 2015 | 67 | 0.030 |
Why?
| | Hospitals, High-Volume | 1 | 2015 | 39 | 0.030 |
Why?
| | Materials Testing | 1 | 2016 | 337 | 0.030 |
Why?
| | Ventricular Outflow Obstruction | 1 | 2015 | 38 | 0.030 |
Why?
| | International Classification of Diseases | 1 | 2015 | 116 | 0.030 |
Why?
| | Elective Surgical Procedures | 1 | 2015 | 151 | 0.030 |
Why?
| | Solvents | 1 | 2014 | 104 | 0.030 |
Why?
| | Injections | 1 | 2014 | 159 | 0.030 |
Why?
| | Young Adult | 2 | 2020 | 10471 | 0.030 |
Why?
| | Death, Sudden | 1 | 2012 | 27 | 0.030 |
Why?
| | Hospitalization | 1 | 2021 | 1752 | 0.020 |
Why?
| | Cohort Studies | 2 | 2012 | 4895 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2019 | 2765 | 0.020 |
Why?
| | Patient Safety | 1 | 2015 | 277 | 0.020 |
Why?
| | Inflammation | 1 | 2022 | 2480 | 0.020 |
Why?
| | Early Diagnosis | 1 | 2011 | 217 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2011 | 493 | 0.020 |
Why?
| | Adolescent | 2 | 2020 | 17853 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2019 | 4410 | 0.020 |
Why?
| | Models, Biological | 1 | 2016 | 1621 | 0.020 |
Why?
| | Odds Ratio | 1 | 2011 | 953 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2011 | 1226 | 0.020 |
Why?
| | Biopsy | 1 | 2011 | 1036 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2011 | 1693 | 0.020 |
Why?
| | Logistic Models | 1 | 2011 | 1841 | 0.020 |
Why?
|
|
Zipse's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|